Not all start-ups are built on the internet.
Boston-based Ginkgo Bioworks, for one, is creating new bacteria, and is now working on a vaccine to protect people from the "bad" bacteria that causes ailments like antibiotic-resistant infections and traveler's diarrhea.
An illness like Traveler's diarrhea might be just a pesky annoyance to some, but to the U.S. Department of Defense it's a significant problem. It can severely hamper soldiers' field operations, and thus the DOD has given Ginko $1.75 million to make a vaccine, said Patrick Boyle, head of design at Ginkgo Bioworks.
"You take 100,000 people and move them to new country, a significant percentage of that group will get sick with traveler's diarrhea," said Boyle. "That happens to be a disease that is a disruption of your gut microbiome by bad bacteria."